• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Economic evaluation of intensive care treatment from a view of safety management

Research Project

Project/Area Number 15590455
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Medical sociology
Research InstitutionNagoya University

Principal Investigator

SAKAKIBARA Yoko  Nagoya University, University Hospital, Assistant Professor, 医学部附属病院, 助手 (50262910)

Project Period (FY) 2003 – 2005
Project Status Completed (Fiscal Year 2005)
Budget Amount *help
¥3,100,000 (Direct Cost: ¥3,100,000)
Fiscal Year 2005: ¥1,200,000 (Direct Cost: ¥1,200,000)
Fiscal Year 2004: ¥600,000 (Direct Cost: ¥600,000)
Fiscal Year 2003: ¥1,300,000 (Direct Cost: ¥1,300,000)
Keywordsintensive care / hospital acquired infection / ventilator associated pneumonia / heparin induced thrombocytopenia / economic evaluation / safety management / cost / ヘパリン誘発性血小板減少症 / 患者転帰
Research Abstract

As hospital acquired infection, especially ventilator associated pneumonia (VAP), and heparin induced thrombothytopenia (HIT) affects patients outcome and cost in intensive care unit, we collected patients data and investigated correlation of these data.
Concerning to hospital acquired infection, we examined patient's outcome, duration of hospital and ICU stay, ventilated days and cost who had VAP in ICU. There are correlation between duration of hospital stay and outcome, duration of hospital stay and ventilated days, duration of hospital stay and cost. These show that extra cost is caused, because VAP acts on prolonging days on ventilator and hospital stay. Then, not only patients but also hospitals suffer a loss of profits and confidence about hospital management.
Regarding to HIT, as we often give heparin to patients in ICU, it may increase occurrence of HIT. Number of platelets and HIT antibody were measured for the investigation of the prediction of HIT's happening and the possibility of HIT's screening. The HIT antibody did not detect any patient who was diagnosed HIT clinically because of symptoms. There is no compatibility of appearance between antibody and symptoms. It shows it is impossible to predict of occurrence of HIT by examination of HIT antibody, or dose/ way to prescribe heparin. Further, it costs much when the HIT antibody is used as screening to detect HIT.

Report

(4 results)
  • 2005 Annual Research Report   Final Research Report Summary
  • 2004 Annual Research Report
  • 2003 Annual Research Report
  • Research Products

    (4 results)

All Other

All Publications (4 results)

  • [Publications] 榊原陽子: "国立大学医学部附属病院感染対策協議会 病院感染対策ガイドライン"Medical Technology. 31・4. 350-351 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] 榊原陽子: "厚生労働省のサーベイランス事業(ICU)"Infection Control 感染対策ICT教育・活動ガイド. 増刊. 147-151 (2003)

    • Related Report
      2003 Annual Research Report
  • [Publications] 榊原陽子: "末梢静脈・中心静脈カテーテル由来感染の防止"OPE Nursing. 19・2. 51-56 (2004)

    • Related Report
      2003 Annual Research Report
  • [Publications] 国立大学医学部附属病院感染対策協議会: "病院感染対策ガイドライン"国立大学医学部附属病院感染対策協議会病院感染対策ガイドライン(第2版). (2003)

    • Related Report
      2003 Annual Research Report

URL: 

Published: 2003-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi